Post Abortion IUD & Recurrent Abortion 2005-2006

Status Terminated

Clinical Trial Summary

The rate of repeat abortions will be lowest in those women who choose immediate insertion of an IUD post-abortion versus those who immediately choose oral contraceptive pills and those who indicate all other contraceptive choices including no contraception The provision by the health system of IUDs for immediate insertion will result in the lowest health system costs.

Clinical Trial Description

The investigators intend to demonstrate whether there are statistically significant differences in the rates of repeat abortions between three groups: 1. women choosing to have an intrauterine device (IUD) inserted immediately post-abortion, 2. those choosing to begin oral contraceptives immediately post-abortion, and 3. all other choices for post abortion contraception including those stating an intention to obtain contraceptives at a later time or from an alternate location or to use no contraception. This data will then be used to conduct a cost-effectiveness analysis of health system provision for cost-free IUDs post-abortion. Thus, if providing a free IUD immediately post-abortion significantly reduces the rate of repeat abortions, it may be more cost- effective for health system services to provide free IUDs at abortion clinics than to field the costs associated with a higher rate of repeat abortions.

The researchers will conduct a retrospective observational cohort study by chart review. The researchers propose to review the charts of women undergoing abortions between January 1, 2005 and December 31, 2006 at Kelowna General Hospital's Women's Services Clinic. The researchers will record the following data from each chart: age, parity, gestational age, date of index therapeutic abortion (TA), dates of subsequent TAs, contraception used at the time of the index conception, contraceptive method chosen post-abortion, and outcome of follow-up at two weeks, such as expulsion of IUD. The researchers will also record the recurrent pregnancy rates. ;

Study Design

Related Conditions & MeSH terms

Induced Abortion

Clinical Trial Details

NCT number	NCT01776957
Study type	Observational
Source	University of British Columbia
Contact
Status	Terminated
Phase
Start date	July 2012
Completion date	December 2012

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02208596` - The Feasibility of Different Doses of Etomidate Admixed With Propofol in Induced Abortion: A Randomized, Double Blind Controlled Trial	Phase 4
Completed	`NCT02412618` - Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation	Phase 4
Completed	`NCT01842100` - To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy	N/A
Completed	`NCT00540748` - Is Oxytocin Given During Surgical Procedure for Abortion Before 12 Weeks of Pregnancy Useful?	N/A
Completed	`NCT03727308` - Study of Clinic-based Versus Self-use of Medical Abortion Pills
Completed	`NCT00482209` - Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation	N/A
Recruiting	`NCT04242212` - Study of Clinic-based vs. Self-use of a Misoprostol-only Regimen for Induced Abortion
Completed	`NCT00621543` - Insertion of an Intrauterine Device (IUD) After Medical Abortion	N/A
Recruiting	`NCT01636063` - Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks	N/A
Completed	`NCT01173003` - Expansion Study of a Simplified Regimen of Medical Abortion Thru 63 Last Menstrual Period (LMP) in Tunisia	N/A
Completed	`NCT05532085` - Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
Completed	`NCT01047748` - A Trial of Digoxin Before Second-Trimester Abortion	N/A
Completed	`NCT00401440` - Comparison of Two Regimens of Misoprostol for Second Trimester Medical Termination of Pregnancy	Phase 4
Completed	`NCT00619658` - The Feasibility of Simplified Telephone Follow-up After Medical Abortion	N/A
Completed	`NCT00324519` - Randomized Trial Comparing Misoprostol and Foley Bulb for Pregnancy Termination in the Second Trimester	Phase 4
Completed	`NCT04181541` - Midlevel Versus Physician-provided Medical Abortion in the Second Trimester	N/A
Completed	`NCT00286208` - Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation	N/A
Completed	`NCT01085825` - Study of the Sensitivity of Manual vs Electric Aspiration to Detect Completed Early Abortion	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.